EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT · NASDAQ Global Market
+$0.26 today
Vol 1.24M · Avg 0.95M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+64.01%
Period High
$18.85
Period Low
$8.28
Latest
$13.58
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Tango Therapeutics, Inc.
NASDAQ:TNGX
$3.55B
Kodiak Sciences Inc.
NASDAQ:KOD
$1.87B
Septerna, Inc.
NASDAQ:SEPN
$1.57B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
$1.49B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.25B
Savara Inc.
NASDAQ:SVRA
$1.11B
Kura Oncology, Inc.
NASDAQ:KURA
$854.90M
Prime Medicine, Inc.
NASDAQ:PRME
$562.62M
Rezolute, Inc.
NASDAQ:RZLT
$487.72M
ProKidney Corp.
NASDAQ:PROK
$261.50M
What is the latest EYPT filing?
The latest filing shown is 4 dated May 27, 2026.
How many recent filings does EYPT have?
Intrinsic Alpha currently shows 20 recent filings for EYPT.
Explore More
Continue the stock analysis
Jump to another research area for this company.